Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-16-113919

Co-Chief Executive Officer acquired 67,567 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MOHANTY ADITYA P. · Co-Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-04-11 Grant or award : show line 1 in the form +67,567 $2.96 $199,998 67,567 D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-04-07 Grant or award : show line 2 in the form Option to Purchase Common Shares +375,000 $3.16 2026-04-06 375,000 375,000 D
2016-04-11 Grant or award : show line 3 in the form Restricted Stock Units +75,000 75,000 75,000 D
Loading xslF345X03/doc4.xml…